Form 4: Guardant Health Director Converts RSUs to Common Stock

Guardant Health Director Roberto Mignone converted 264 Restricted Stock Units into common stock, increasing his direct holdings.

Summary

• Roberto Mignone, a Director at Guardant Health, Inc. (GH), acquired 264 shares of common stock through the conversion of Restricted Stock Units (RSUs).
• The transaction occurred on February 21, 2026, with a price of $0 per share, typical for RSU conversions.
• Following this transaction, Mignone directly beneficially owns 4,223 shares of Guardant Health common stock.
• Mignone also holds 8,448 Restricted Stock Units (RSUs) directly.
• The RSU award, granted on November 8, 2024, vests over a four-year period, with 25% vesting on the one-year anniversary of October 21, 2024, and the remaining 75% vesting monthly for the subsequent three years.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive, routine event. While not indicative of new strategic moves, the conversion increases the director's direct equity stake, aligning interests with shareholders without suggesting any immediate concerns.

Positives

• The conversion of Restricted Stock Units into common stock increases Director Roberto Mignone's direct ownership in Guardant Health, aligning his interests further with shareholders.
• The transaction is part of a pre-scheduled vesting plan, indicating a routine and expected increase in insider holdings.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those involving the conversion of Restricted Stock Units (RSUs) into common stock, are common and often reflect pre-scheduled compensation plans rather than discretionary buying or selling. Such routine conversions typically do not signal significant shifts in company outlook or performance, but rather a director's continued accumulation of equity as part of their compensation.

Stakeholder Impact

• Shareholders: The transaction slightly increases the director's direct ownership, potentially reinforcing confidence in management's alignment with shareholder interests.

Next Steps

• The remaining 8,448 Restricted Stock Units (RSUs) held by Roberto Mignone will continue to vest monthly over the three-year period following October 21, 2025.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-scheduled conversion of Restricted Stock Units (RSUs) by a director. Such transactions are part of standard executive compensation and do not typically provide new fundamental information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Guardant Health, GH, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director, Roberto Mignone